Fatty Liver Diseases: A Public Health Concern, But Market Opportunity

A new epidemiological analysis suggests the increasing number of patients from across the globe with some form of non-alcoholic fatty liver disease promises an effective therapy would be a welcome addition to the armamentarium of liver disease specialists.

Liver

More from R&D

More from Scrip